-
1
-
-
0028332826
-
Treatment of hepatocellular carcinoma: Too many options?
-
Venook, A. P. Treatment of hepatocellular carcinoma: too many options? J. Clin. Oncol., 12: 1323-1334, 1994.
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 1323-1334
-
-
Venook, A.P.1
-
2
-
-
0029065587
-
Therapy of unresectable hepatocellular carcinoma
-
Levin, B., and Amos, C. Therapy of unresectable hepatocellular carcinoma. N. Engl. J. Med., 332: 1294-1296, 1995.
-
(1995)
N. Engl. J. Med.
, vol.332
, pp. 1294-1296
-
-
Levin, B.1
Amos, C.2
-
3
-
-
0027230578
-
Postresection prognosis of patients with hepatocellular carcinoma
-
St. Louis
-
Sugioka, A., Tsuzuki, T., and Kanai, T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery (St. Louis), 113: 612-618, 1993.
-
(1993)
Surgery
, vol.113
, pp. 612-618
-
-
Sugioka, A.1
Tsuzuki, T.2
Kanai, T.3
-
4
-
-
0028217101
-
Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma
-
Tabor, E. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J. Med. Virol., 42: 357-365, 1994.
-
(1994)
J. Med. Virol.
, vol.42
, pp. 357-365
-
-
Tabor, E.1
-
5
-
-
0025876591
-
The p53 tumour suppressor gene
-
Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
-
(1991)
Nature (Lond.)
, vol.351
, pp. 453-456
-
-
Levine, A.J.1
Momand, J.2
Finlay, C.A.3
-
6
-
-
0030043651
-
Characteristic histologic features of human hepatocellular carcinoma with mutant p53 protein
-
Okuda, T., Hirohashi, K., Kinoshita, H., Wakasa, K., and Sakurai, M. Characteristic histologic features of human hepatocellular carcinoma with mutant p53 protein. World J. Surg., 20: 215-220, 1996.
-
(1996)
World J. Surg.
, vol.20
, pp. 215-220
-
-
Okuda, T.1
Hirohashi, K.2
Kinoshita, H.3
Wakasa, K.4
Sakurai, M.5
-
7
-
-
0020079972
-
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
-
Sarnow, P., Ho, Y. S., Williams, J., and Levine, A. J. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell, 28: 387-394, 1982.
-
(1982)
Cell
, vol.28
, pp. 387-394
-
-
Sarnow, P.1
Ho, Y.S.2
Williams, J.3
Levine, A.J.4
-
8
-
-
0026560315
-
Inhibition of p53 transactivation required for transformation by adenovirus early IB protein
-
Yew, P. R., and Berk, A. J. Inhibition of p53 transactivation required for transformation by adenovirus early IB protein. Nature (Lond.), 557: 82-85, 1992.
-
(1992)
Nature (Lond.)
, vol.557
, pp. 82-85
-
-
Yew, P.R.1
Berk, A.J.2
-
9
-
-
0023099280
-
Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection
-
Barker, D. D., and Berk, A. J. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology, 156: 107-121, 1987.
-
(1987)
Virology
, vol.156
, pp. 107-121
-
-
Barker, D.D.1
Berk, A.J.2
-
10
-
-
0344188096
-
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
-
Washington DC
-
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., and McCormick, F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science (Washington DC), 274: 373-376, 1996.
-
(1996)
Science
, vol.274
, pp. 373-376
-
-
Bischoff, J.R.1
Kirn, D.H.2
Williams, A.3
Heise, C.4
Horn, S.5
Muna, M.6
Ng, L.7
Nye, J.A.8
Sampson-Johannes, A.9
Fattaey, A.10
McCormick, F.11
-
11
-
-
0030917202
-
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
-
Heise, C., Sampson-Johannes, A., Williams, A., McCormick, F., Von Hoff, D. D., and Kirn, D. H. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med., 3: 639-645, 1997.
-
(1997)
Nat. Med.
, vol.3
, pp. 639-645
-
-
Heise, C.1
Sampson-Johannes, A.2
Williams, A.3
McCormick, F.4
Von Hoff, D.D.5
Kirn, D.H.6
-
12
-
-
0031697770
-
p53-dependent cell death/apoptosis is required for a productive adenovirus infection
-
Hall, A. R., Dix, B. R., O'Carroll, S. J., and Braithwaite, A. W. p53-dependent cell death/apoptosis is required for a productive adenovirus infection. Nat. Med., 4: 1068-1072, 1998.
-
(1998)
Nat. Med.
, vol.4
, pp. 1068-1072
-
-
Hall, A.R.1
Dix, B.R.2
O'Carroll, S.J.3
Braithwaite, A.W.4
-
13
-
-
0018718742
-
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
-
Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I., and Knowles, B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (Lond.), 282: 615-616, 1979.
-
(1979)
Nature (Lond.)
, vol.282
, pp. 615-616
-
-
Aden, D.P.1
Fogel, A.2
Plotkin, S.3
Damjanov, I.4
Knowles, B.B.5
-
14
-
-
0031564326
-
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2
-
Bui, L. A., Butterfield, L. H., Kim, J. Y., Ribas, A., Seu, P., Lau, R., Glaspy, J. A., McBride, W. H., and Economou, J. S. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. Hum. Gene Ther., 8: 2173-2182, 1997.
-
(1997)
Hum. Gene Ther.
, vol.8
, pp. 2173-2182
-
-
Bui, L.A.1
Butterfield, L.H.2
Kim, J.Y.3
Ribas, A.4
Seu, P.5
Lau, R.6
Glaspy, J.A.7
McBride, W.H.8
Economou, J.S.9
-
15
-
-
0025262417
-
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma
-
Bressac, B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., and Ozturk, M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 1973-1977, 1990.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 1973-1977
-
-
Bressac, B.1
Galvin, K.M.2
Liang, T.J.3
Isselbacher, K.J.4
Wands, J.R.5
Ozturk, M.6
-
16
-
-
0027207612
-
p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines
-
Lond.
-
Hsu, I. C., Tokiwa, T., Bennett, W., Metcalf, R. A., Welsh, J. A., Sun, T., and Harris, C. C. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis (Lond.), 14: 987-992, 1993.
-
(1993)
Carcinogenesis
, vol.14
, pp. 987-992
-
-
Hsu, I.C.1
Tokiwa, T.2
Bennett, W.3
Metcalf, R.A.4
Welsh, J.A.5
Sun, T.6
Harris, C.C.7
-
17
-
-
0031060333
-
The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle
-
Goodrum, F. D., and Ornelles, D. A. The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle. J. Virol., 71: 548-561, 1997.
-
(1997)
J. Virol.
, vol.71
, pp. 548-561
-
-
Goodrum, F.D.1
Ornelles, D.A.2
-
18
-
-
0025953696
-
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
-
Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 5523-5527
-
-
Scheffner, M.1
Munger, K.2
Byrne, J.C.3
Howley, P.M.4
-
19
-
-
0029691138
-
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector
-
Toloza, E. M., Hunt, K., Swisher, S., McBride, W., Lau, R., Pang, S., Rhoades, K., Drake, T., Belldegrun, A., Glaspy, J., and Economou, J. S. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther., 3: 11-17, 1996.
-
(1996)
Cancer Gene Ther.
, vol.3
, pp. 11-17
-
-
Toloza, E.M.1
Hunt, K.2
Swisher, S.3
McBride, W.4
Lau, R.5
Pang, S.6
Rhoades, K.7
Drake, T.8
Belldegrun, A.9
Glaspy, J.10
Economou, J.S.11
-
20
-
-
0031052263
-
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
-
Washington DC
-
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., and Finberg, R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (Washington DC), 275: 1320-1323, 1997.
-
(1997)
Science
, vol.275
, pp. 1320-1323
-
-
Bergelson, J.M.1
Cunningham, J.A.2
Droguett, G.3
Kurt-Jones, E.A.4
Krithivas, A.5
Hong, J.S.6
Horwitz, M.S.7
Crowell, R.L.8
Finberg, R.W.9
-
21
-
-
0017710978
-
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
-
Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36: 59-74, 1977.
-
(1977)
J. Gen. Virol.
, vol.36
, pp. 59-74
-
-
Graham, F.L.1
Smiley, J.2
Russell, W.C.3
Nairn, R.4
|